Analytical Data
-
基因名
RGC32
- Application
-
别名
RGC32；C13orf15；RGC32；Regulator of cell cycle RGCC
-
种属
Human
-
表达系统
E. coli
-
标签
His tag N-Terminus
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q9H4X1
-
表达区间
1-137aa
-
氨基酸序列
MKPPAAQGSP AAAAAAAPAL DSAAAEDLSD ALCEFDAVLA DFASPFHERH FHYEEHLERM KRRSSASVSD SSGFSDSESA DSLYRNSFSF SDEKLNSPTD STPALLSATV TPQKAKLGDT KELEAFIADL DKTLASM
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
RGC32, or Regulator of G-protein signaling 32, is a protein that plays a crucial role in various cellular processes, including cell proliferation, differentiation, and apoptosis. Its expression is often associated with specific tissues and has been implicated in several physiological and pathological conditions, particularly in cancerous tissues. The interest in RGC32 research stems from its regulatory effects on G-protein signaling pathways, which are essential for transmitting extracellular signals to the cell's interior. Abnormalities in these pathways can lead to unchecked cell growth and tumor development. Recent studies have indicated that RGC32 may act as a tumor suppressor in certain contexts, making it a potential target for therapeutic interventions. Moreover, the ability to produce recombinant RGC32 protein allows for detailed characterizations of its functional properties and interactions with other signaling molecules. Such research could provide insights into its mechanisms of action and its potential implications in cancer biology and treatment. Understanding the role of RGC32 in cellular signaling may therefore reveal novel therapeutic strategies to combat cancers where this pathway is dysregulated.
